Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Pairwise Plants | 2024 | Series C | $40.0M | Durham |
| AdaptHealth | 2024 | Post Ipo Debt | $950.0M | Phoenixville |
| Vesta Healthcare | 2024 | Debt Financing | $10.0M | New York |
| Frontier Medicines | 2024 | Series C | $20.0M | San Francisco |
| Elutia | 2024 | Post Ipo Equity | $13.3M | Silver Spring |
| CorVent Medical | 2024 | Grant | $3.0M | Fargo |
| Advanced Medicine Partners | 2024 | Series A | $32.0M | Lake Forest |
| R3 Vascular | 2024 | Series B | $87.0M | Mountain View |
| MMI | 2024 | Series C | $110.0M | Pisa |
| Adela | 2023 | Series A | $48.0M | Foster City |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 101 | Pairwise Plants | Series C | $40.0M | Durham, United States |
| 102 | AdaptHealth | Post Ipo Debt | $950.0M | Phoenixville, United States |
| 103 | Vesta Healthcare | Debt Financing | $10.0M | New York, United States |
| 104 | Frontier Medicines | Series C | $20.0M | San Francisco, United States |
| 105 | Elutia | Post Ipo Equity | $13.3M | Silver Spring, United States |
| 106 | CorVent Medical | Grant | $3.0M | Fargo, United States |
| 107 | Advanced Medicine Partners | Series A | $32.0M | Lake Forest, United States |
| 108 | R3 Vascular | Series B | $87.0M | Mountain View, United States |
| 109 | MMI | Series C | $110.0M | Pisa, Italy |
| 110 | Adela | Series A | $48.0M | Foster City, United States |
Pairwise is a purpose-driven food+tech company dedicated to building a healthier world through better fruits and vegetables.
AdaptHealth is a provider of home healthcare equipment, medical supplies to the home and related services in the United States.
Vesta Healthcare is a technology and clinical services organization that offers virtual care services.
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.
Elutia is a developer of customized tissue products intended to restore health and mobility to the greatest number of patients.
We provide simple, sophisticated respiratory solutions for post-ICU and home environments, eliminating unnecessary cost and complexity.
Advanced Medicine Partners is a biotechnology company that specializes in viral vector manufacturing for genes and cells.
R3 Vascular is a medical device company that develops new therapies to treat peripheral artery disease.
MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients.
Presidio Medical is a medtech company that develops a transformational neuromodulation platform.
Twill is a technology healing firm that provides engaged communities, healthcare providers, mental health services, and treatment options.
Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.
Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.
Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.
MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.
Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.
Bringing clarity to cancer. Working to ensure that everyone touched by cancer has a clear path to the right care.
Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.
CathWorks is a medical technology company focused transforming how cardiovascular disease is diagnosed and treated.
Platform therapeutics company advancing novel treatments for Oncology, Neurodegenerative Disorders, and Rare Diseases
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Apertura Gene Therapy is a biotechnology company that treats debilitating diseases with limited options.
Aurion Biotechnologies is a clinical-stage biotech company.
Deerfield has invested in 160 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Deerfield's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Therapeutics. The firm invests across 30 different industry categories.
Among tracked funding rounds, AdaptHealth received $950.0M in a Post Ipo Debt round. Deerfield's total known invested capital is $8.0B.
Deerfield's average investment size is $78.0M across its portfolio of 160 companies.
Recent Deerfield portfolio additions include Pairwise Plants, AdaptHealth, Vesta Healthcare, Frontier Medicines, Elutia. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors